↓ Skip to main content

PLOS

A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy…

Overview of attention for article published in PLOS ONE, January 2014
Altmetric Badge

Mentioned by

news
14 news outlets
policy
2 policy sources
twitter
19 X users
patent
1 patent
facebook
3 Facebook pages

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
115 Mendeley
Title
A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers
Published in
PLOS ONE, January 2014
DOI 10.1371/journal.pone.0083449
Pubmed ID
Authors

Rigmor Thorstensson, Birger Trollfors, Nabil Al-Tawil, Maja Jahnmatz, Jakob Bergström, Margaretha Ljungman, Anna Törner, Lena Wehlin, Annie Van Broekhoven, Fons Bosman, Anne-Sophie Debrie, Nathalie Mielcarek, Camille Locht

Abstract

Acellular pertussis vaccines do not control pertussis. A new approach to offer protection to infants is necessary. BPZE1, a genetically modified Bordetella pertussis strain, was developed as a live attenuated nasal pertussis vaccine by genetically eliminating or detoxifying 3 toxins.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
France 1 <1%
Canada 1 <1%
Unknown 112 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 19%
Student > Ph. D. Student 16 14%
Student > Bachelor 13 11%
Student > Master 12 10%
Other 9 8%
Other 15 13%
Unknown 28 24%
Readers by discipline Count As %
Medicine and Dentistry 22 19%
Immunology and Microbiology 20 17%
Agricultural and Biological Sciences 19 17%
Biochemistry, Genetics and Molecular Biology 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 8 7%
Unknown 34 30%